Momecort (Mometasone Furoate)

Mometasone furoate binds to glucocorticoid receptors inside skin cells, altering gene expression. This suppresses the synthesis of pro‑inflammatory cytokines and mediators, leading to decreased cellular infiltration, edema, and immune activation, which collectively reduce inflammation and symptoms.

The appropriate dose of Momecort is determined by the prescribing healthcare professional based on the specific condition, severity, patient age, and treatment area. Patients should follow the prescriber’s instructions and not exceed the recommended amount.

The safety of Momecort in pregnancy and lactation has not been definitively established. Healthcare providers should weigh potential benefits against possible risks and consider alternative therapies when appropriate. Pregnant or nursing individuals should discuss use with their clinician.

To request Momecort, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Momecort (mometasone furoate) is a high‑potency topical glucocorticoid, offering strong anti‑inflammatory effects with once‑daily application in many cases. Compared with lower‑potency steroids, it may achieve faster symptom control but also carries a higher risk of local side effects if used excessively.

Store Momecort at room temperature, below 25 °C. Keep the tube or container tightly closed, protect it from moisture and direct sunlight, and retain it in the original packaging until use.

Momecort should be applied thinly to clean, dry skin on the affected area, usually once daily unless otherwise directed. Wash hands before and after application, avoid contact with eyes, and do not cover the treated skin with airtight dressings unless instructed by a healthcare professional.

Serious risks include skin atrophy, secondary infections, systemic corticosteroid effects such as adrenal suppression when large body surface areas are treated, and rare ocular complications if used near the eyes. Patients should report any unusual symptoms promptly to their clinician.

Momecort should be avoided in individuals with known hypersensitivity to mometasone furoate or any formulation components, in patients with untreated skin infections at the application site, and in children under the age specified by the prescriber without professional guidance.